Herlev Hospital: Melanoma trials

The registry lists 10 Melanoma studies with Herlev Hospital as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 1 4Phase 2 2No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Dermoscopy Augmented Histology Trial, a Randomized Controlled TrialNot yet recruitingNCT05004792Not applicable
• Arginase-1 Peptide Vaccine in Patients With Metastatic Solid TumorsCompletedNCT03689192Phase 1Results posted
• Safety and Avoidance of Futile Excisions Through Skin Tele-triageCompletedNCT05982600
• Dermoscopy Augmented Histology Trial, Consensus Agreement Diagnosis Made by Dermatopathology ExpertsCompletedNCT05712551
• App Teaches Doctors to Diagnose Skin CancerCompletedNCT05661370Not applicable
• AI Augmented Training for Skin SpecialistsCompletedNCT04758988Not applicable
• Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac)Status unknownNCT03715985Phase 1/2
• Quality of Life and Surgical Late Effects of Melanoma TreatmentCompletedNCT02352623
• Vaccination With Peptides in Combination With Either Ipilimumab or Vemurafenib for the Treatment of Unresectable Stage III or IV Malignant MelanomaCompletedNCT02077114Phase 1
• Dendritic Cell Based Therapy of Malignant MelanomaCompletedNCT00197912Phase 1/2